Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NVO |
---|---|---|
09:32 ET | 11776 | 101.495 |
09:33 ET | 6200 | 101.335 |
09:35 ET | 223181 | 101.06 |
09:37 ET | 60158 | 101.61 |
09:39 ET | 41155 | 101.7539 |
09:42 ET | 35366 | 101.53 |
09:44 ET | 35530 | 101.6517 |
09:46 ET | 33397 | 101.62 |
09:48 ET | 54240 | 101.67 |
09:50 ET | 27752 | 101.8445 |
09:51 ET | 42381 | 102.02 |
09:53 ET | 28428 | 101.9428 |
09:55 ET | 61141 | 101.63 |
09:57 ET | 45422 | 101.6025 |
10:00 ET | 20128 | 101.5 |
10:02 ET | 28847 | 101.41 |
10:04 ET | 30867 | 101.605 |
10:06 ET | 27171 | 101.76 |
10:08 ET | 22763 | 101.78 |
10:09 ET | 27595 | 101.59 |
10:11 ET | 38289 | 101.69 |
10:13 ET | 27761 | 101.61 |
10:15 ET | 17348 | 101.54 |
10:18 ET | 20395 | 101.48 |
10:20 ET | 38115 | 101.5 |
10:22 ET | 15681 | 101.371 |
10:24 ET | 26360 | 101.38 |
10:26 ET | 55638 | 101.3538 |
10:27 ET | 67350 | 101.34 |
10:29 ET | 38415 | 101.45 |
10:31 ET | 31522 | 101.28 |
10:33 ET | 43112 | 101.19 |
10:36 ET | 39352 | 101.17 |
10:38 ET | 36119 | 101 |
10:40 ET | 38967 | 101.13 |
10:42 ET | 27271 | 101.13 |
10:44 ET | 44877 | 100.88 |
10:45 ET | 40113 | 100.89 |
10:47 ET | 50157 | 100.9398 |
10:49 ET | 37239 | 100.91 |
10:51 ET | 57855 | 101.21 |
10:54 ET | 230020 | 100.49 |
10:56 ET | 117567 | 100.635 |
10:58 ET | 68750 | 100.54 |
11:00 ET | 69168 | 100.57 |
11:02 ET | 52071 | 100.525 |
11:03 ET | 52729 | 100.684 |
11:05 ET | 27515 | 100.68 |
11:07 ET | 36954 | 100.8 |
11:09 ET | 55894 | 101.14 |
11:12 ET | 37692 | 101.13 |
11:14 ET | 43924 | 101.165 |
11:16 ET | 34016 | 101.175 |
11:18 ET | 16760 | 101.325 |
11:20 ET | 22368 | 101.42 |
11:21 ET | 48306 | 101.521 |
11:23 ET | 32341 | 101.505 |
11:25 ET | 12231 | 101.51 |
11:27 ET | 13375 | 101.45 |
11:30 ET | 9013 | 101.44 |
11:32 ET | 12564 | 101.52 |
11:34 ET | 72038 | 101.74 |
11:36 ET | 74532 | 102.05 |
11:38 ET | 80034 | 102 |
11:39 ET | 52369 | 102.18 |
11:41 ET | 38975 | 102.2503 |
11:43 ET | 37460 | 102.145 |
11:45 ET | 88737 | 102.045 |
11:48 ET | 47127 | 102.185 |
11:50 ET | 98416 | 102.19 |
11:52 ET | 20853 | 102.145 |
11:54 ET | 38431 | 102.06 |
11:56 ET | 14021 | 102.07 |
11:57 ET | 25290 | 101.97 |
11:59 ET | 16323 | 101.87 |
12:01 ET | 37421 | 101.875 |
12:03 ET | 25032 | 101.8 |
12:06 ET | 69023 | 101.81 |
12:08 ET | 10732 | 101.82 |
12:10 ET | 25879 | 101.92 |
12:12 ET | 32798 | 101.79 |
12:14 ET | 27988 | 102.002 |
12:15 ET | 11614 | 102.09 |
12:17 ET | 8372 | 102.05 |
12:19 ET | 5423 | 102.095 |
12:21 ET | 22876 | 101.95 |
12:24 ET | 20188 | 101.99 |
12:26 ET | 7308 | 101.927174 |
12:28 ET | 15108 | 101.9 |
12:30 ET | 22143 | 101.68 |
12:32 ET | 23943 | 101.64 |
12:33 ET | 15882 | 101.56 |
12:35 ET | 32689 | 101.695 |
12:37 ET | 14564 | 101.63 |
12:39 ET | 6893 | 101.74 |
12:42 ET | 12709 | 101.52 |
12:44 ET | 26194 | 101.48 |
12:46 ET | 10602 | 101.63 |
12:48 ET | 10048 | 101.625 |
12:50 ET | 7826 | 101.55 |
12:51 ET | 15265 | 101.47 |
12:53 ET | 13825 | 101.44 |
12:55 ET | 13682 | 101.485 |
12:57 ET | 5711 | 101.46 |
01:00 ET | 20166 | 101.485 |
01:02 ET | 11816 | 101.51 |
01:04 ET | 10661 | 101.5 |
01:06 ET | 42565 | 101.74 |
01:08 ET | 8858 | 101.72 |
01:09 ET | 8282 | 101.75 |
01:11 ET | 28692 | 101.68 |
01:13 ET | 49644 | 101.685 |
01:15 ET | 11249 | 101.76 |
01:18 ET | 13213 | 101.745 |
01:20 ET | 12483 | 101.75 |
01:22 ET | 24717 | 101.81 |
01:24 ET | 172125 | 101.92 |
01:26 ET | 11669 | 101.91 |
01:27 ET | 16443 | 101.89 |
01:29 ET | 11855 | 101.965 |
01:31 ET | 11963 | 101.88 |
01:33 ET | 24301 | 101.905 |
01:36 ET | 13020 | 101.8286 |
01:38 ET | 8617 | 101.855 |
01:40 ET | 11642 | 101.8 |
01:42 ET | 8536 | 101.88 |
01:44 ET | 6457 | 101.8687 |
01:45 ET | 19333 | 101.9299 |
01:47 ET | 12652 | 101.86 |
01:49 ET | 6804 | 101.8139 |
01:51 ET | 8913 | 101.8767 |
01:54 ET | 7026 | 101.86 |
01:56 ET | 7262 | 101.85 |
01:58 ET | 9349 | 101.95 |
02:00 ET | 9324 | 101.85 |
02:02 ET | 12573 | 101.88 |
02:03 ET | 28960 | 101.8879 |
02:05 ET | 11579 | 101.93 |
02:07 ET | 23492 | 101.8677 |
02:09 ET | 14650 | 101.84 |
02:12 ET | 5482 | 101.8477 |
02:14 ET | 11589 | 101.84 |
02:16 ET | 12371 | 101.83 |
02:18 ET | 17409 | 101.85 |
02:20 ET | 22253 | 101.865 |
02:21 ET | 7846 | 101.81 |
02:23 ET | 16115 | 101.8 |
02:25 ET | 10291 | 101.75 |
02:27 ET | 11589 | 101.6899 |
02:30 ET | 14443 | 101.72 |
02:32 ET | 10221 | 101.77 |
02:34 ET | 11888 | 101.82 |
02:36 ET | 38026 | 101.71 |
02:38 ET | 21541 | 101.61 |
02:39 ET | 15361 | 101.7 |
02:41 ET | 11609 | 101.7 |
02:43 ET | 25959 | 101.82 |
02:45 ET | 1793 | 101.8001 |
03:14 ET | 391 | 101.86 |
03:15 ET | 16145 | 101.82 |
03:17 ET | 17321 | 101.81 |
03:19 ET | 16316 | 101.78 |
03:21 ET | 12442 | 101.85 |
03:24 ET | 28593 | 101.8981 |
03:26 ET | 20474 | 101.78 |
03:28 ET | 16102 | 101.85 |
03:30 ET | 12828 | 101.84 |
03:32 ET | 19164 | 101.849 |
03:33 ET | 21814 | 101.8 |
03:35 ET | 15853 | 101.8382 |
03:37 ET | 31548 | 101.8799 |
03:39 ET | 25072 | 101.94 |
03:42 ET | 25179 | 101.9286 |
03:44 ET | 24108 | 101.83 |
03:46 ET | 22115 | 101.829 |
03:48 ET | 31559 | 101.745 |
03:50 ET | 35038 | 101.695 |
03:51 ET | 39299 | 101.71 |
03:53 ET | 52402 | 101.735 |
03:55 ET | 99626 | 101.775 |
03:57 ET | 101063 | 101.62 |
04:00 ET | 481509 | 101.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Novo Nordisk A/S | 340.3B | 34.0x | +18.50% |
Alnylam Pharmaceuticals Inc | 30.4B | -89.9x | --- |
Catalent Inc | 10.7B | -26.1x | --- |
Perrigo Company PLC | 3.7B | -25.0x | --- |
Royalty Pharma PLC | 15.1B | 10.0x | +1.83% |
Jazz Pharmaceuticals PLC | 7.5B | 17.1x | -3.53% |
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $340.3B |
---|---|
Revenue (TTM) | $38.2B |
Shares Outstanding | 3.4B |
Dividend Yield | 1.42% |
Annual Dividend Rate | 1.4462 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 08-26-24 |
Beta | 0.42 |
EPS | $3.00 |
Book Value | $3.38 |
P/E Ratio | 34.0x |
Price/Sales (TTM) | 8.9 |
Price/Cash Flow (TTM) | 23.2x |
Operating Margin | 43.75% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.